Caitlin B. Conboy

2.8k total citations
23 papers, 1.3k citations indexed

About

Caitlin B. Conboy is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Caitlin B. Conboy has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Oncology. Recurrent topics in Caitlin B. Conboy's work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer-related gene regulation (4 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Caitlin B. Conboy is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Cancer-related gene regulation (4 papers) and Genetics and Neurodevelopmental Disorders (3 papers). Caitlin B. Conboy collaborates with scholars based in United States, Austria and United Kingdom. Caitlin B. Conboy's co-authors include Duncan T. Odom, Ernest Fraenkel, P. Alexander Rolfe, William Gordon, David K. Gifford, Robin D. Dowell, Sumera I. Ilyas, Timothy Danford, Kenzie D. MacIsaac and Emilien Loeuillard and has published in prestigious journals such as Science, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Caitlin B. Conboy

19 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caitlin B. Conboy United States 11 811 264 215 203 184 23 1.3k
Zai Chang China 22 882 1.1× 217 0.8× 220 1.0× 124 0.6× 76 0.4× 29 1.3k
Ting Lei China 23 866 1.1× 164 0.6× 162 0.8× 110 0.5× 100 0.5× 63 1.3k
Xuan Qu United States 21 931 1.1× 222 0.8× 221 1.0× 152 0.7× 74 0.4× 53 1.4k
Celeste Richardson United States 12 1.2k 1.5× 223 0.8× 146 0.7× 113 0.6× 104 0.6× 16 1.6k
Ningning Niu China 16 717 0.9× 252 1.0× 161 0.7× 153 0.8× 93 0.5× 34 1.1k
Liang‐Yi Hung Taiwan 23 840 1.0× 386 1.5× 152 0.7× 88 0.4× 110 0.6× 55 1.4k
Florian Halbritter Austria 18 1.3k 1.6× 179 0.7× 588 2.7× 129 0.6× 136 0.7× 33 2.0k
Yan Jin China 23 773 1.0× 262 1.0× 219 1.0× 102 0.5× 153 0.8× 74 1.3k
Pascal Gélébart Canada 25 1.1k 1.3× 301 1.1× 316 1.5× 120 0.6× 137 0.7× 46 1.7k
Yoshihiko Uehara Japan 15 835 1.0× 187 0.7× 176 0.8× 349 1.7× 182 1.0× 30 1.6k

Countries citing papers authored by Caitlin B. Conboy

Since Specialization
Citations

This map shows the geographic impact of Caitlin B. Conboy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caitlin B. Conboy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caitlin B. Conboy more than expected).

Fields of papers citing papers by Caitlin B. Conboy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caitlin B. Conboy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caitlin B. Conboy. The network helps show where Caitlin B. Conboy may publish in the future.

Co-authorship network of co-authors of Caitlin B. Conboy

This figure shows the co-authorship network connecting the top 25 collaborators of Caitlin B. Conboy. A scholar is included among the top collaborators of Caitlin B. Conboy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caitlin B. Conboy. Caitlin B. Conboy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santol, Jonas, Zhihao Li, Lionel Aurelien Kankeu Fonkoua, et al.. (2025). Conversion to Resection After Neoadjuvant Gemcitabine, Cisplatin, and Nab-Paclitaxel for Borderline Resectable CCA: A Real-World Exploratory Analysis. Annals of Surgical Oncology. 32(10). 7215–7227.
2.
Li, Zhihao, Jonas Santol, Lionel Aurelien Kankeu Fonkoua, et al.. (2025). Real-World Single-Center Experience with Neoadjuvant Gemcitabine, Cisplatin, and Durvalumab in Borderline Resectable Cholangiocarcinoma. Annals of Surgical Oncology. 32(10). 7228–7239.
3.
Larson, Joseph J., Caitlin B. Conboy, Daniel H. Ahn, et al.. (2025). A Phase 1 study of the novel GCN2 kinase activator NXP800 in patients with advanced cholangiocarcinoma. Future Oncology. 21(21). 2723–2730. 1 indexed citations
4.
Abdelhakeem, Ahmed, Jeremy Jones, Caitlin B. Conboy, et al.. (2025). Safety and efficacy analysis of modified TOPAZ-1: A biweekly regimen of gemcitabine and cisplatin plus monthly durvalumab in advanced biliary tract cancer.. Journal of Clinical Oncology. 43(16_suppl).
5.
Yonkus, Jennifer A., Amro M. Abdelrahman, Caitlin B. Conboy, et al.. (2024). YAP ‐ TEAD inhibition is associated with upregulation of an androgen receptor mediated transcription program providing therapeutic escape. FEBS Open Bio. 14(11). 1873–1887. 1 indexed citations
6.
Jatoi, Aminah, Robert R. McWilliams, Zhaohui Jin, et al.. (2024). Prognostication of ß-catenin (CTNNB1) in patients with HCC treated with first line immunotherapy.. Journal of Clinical Oncology. 42(16_suppl). e15146–e15146.
7.
Yonkus, Jennifer A., Rachel Watkins, Aliaa Abdelrahman, et al.. (2021). Novel YAP inhibitor, CA3, demonstrates antitumoral activity in vitro and in vivo model of cholangiocarcinoma. HPB. 23. S510–S511. 1 indexed citations
8.
Loeuillard, Emilien, Jingchun Yang, EeeLN H. Buckarma, et al.. (2020). Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma. Journal of Clinical Investigation. 130(10). 5380–5396. 232 indexed citations
9.
Buckarma, EeeLN H., Nathan W. Werneburg, Caitlin B. Conboy, et al.. (2020). The YAP-Interacting Phosphatase SHP2 Can Regulate Transcriptional Coactivity and Modulate Sensitivity to Chemotherapy in Cholangiocarcinoma. Molecular Cancer Research. 18(10). 1574–1588. 20 indexed citations
10.
Conboy, Caitlin B., Susan K. Rathe, Juan E. Abrahante, et al.. (2020). R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast Cancers. DNA and Cell Biology. 40(1). 70–79. 10 indexed citations
11.
Loeuillard, Emilien, Caitlin B. Conboy, Gregory J. Gores, & Sumera I. Ilyas. (2019). Immunobiology of cholangiocarcinoma. JHEP Reports. 1(4). 297–311. 87 indexed citations
12.
Zandvakili, Inuk, Caitlin B. Conboy, Ayed O. Ayed, Elizabeth Cathcart-Rake, & Ayalew Tefferi. (2018). Ruxolitinib as first‐line treatment in secondary hemophagocytic lymphohistiocytosis: A second experience. American Journal of Hematology. 93(5). 35 indexed citations
13.
Moriarity, Branden S., Eric P. Rahrmann, Caitlin B. Conboy, et al.. (2014). Simple and Efficient Methods for Enrichment and Isolation of Endonuclease Modified Cells. PLoS ONE. 9(5). e96114–e96114. 25 indexed citations
14.
Watson, Adrienne L., Eric P. Rahrmann, Branden S. Moriarity, et al.. (2013). Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance. Cancer Discovery. 3(6). 674–689. 76 indexed citations
15.
Conboy, Caitlin B., Aaron L. Sarver, Kevin A.T. Silverstein, et al.. (2012). Abstract 108: Functional characterization of WAC, a candidate tumor suppressor gene in colorectal cancer. Cancer Research. 72(8_Supplement). 108–108. 1 indexed citations
16.
Wilson, Michael D., Nuno L. Barbosa‐Morais, Dominic Schmidt, et al.. (2008). Species-Specific Transcription in Mice Carrying Human Chromosome 21. Science. 322(5900). 434–438. 224 indexed citations
17.
Conboy, Caitlin B., Christiana Spyrou, Natalie Thorne, et al.. (2007). Cell Cycle Genes Are the Evolutionarily Conserved Targets of the E2F4 Transcription Factor. PLoS ONE. 2(10). e1061–e1061. 44 indexed citations
18.
Odom, Duncan T., Robin D. Dowell, William Gordon, et al.. (2007). Tissue-specific transcriptional regulation has diverged significantly between human and mouse. Nature Genetics. 39(6). 730–732. 408 indexed citations
19.
Conboy, Caitlin B., et al.. (2006). Definitions and Measures of Performance for Standard Biological Parts. DSpace@MIT (Massachusetts Institute of Technology). 2 indexed citations
20.
Blander, Gil, Rita Machado de Oliveira, Caitlin B. Conboy, Marcia C. Haigis, & Leonard Guarente. (2003). Superoxide Dismutase 1 Knock-down Induces Senescence in Human Fibroblasts. Journal of Biological Chemistry. 278(40). 38966–38969. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zai Chang Breakdown of academic impact, for papers by Ting Lei Breakdown of academic impact, for papers by Xuan Qu Breakdown of academic impact, for papers by Celeste Richardson Breakdown of academic impact, for papers by Ningning Niu Breakdown of academic impact, for papers by Liang‐Yi Hung Breakdown of academic impact, for papers by Florian Halbritter Breakdown of academic impact, for papers by Yan Jin Breakdown of academic impact, for papers by Pascal Gélébart Breakdown of academic impact, for papers by Yoshihiko Uehara
Rankless by CCL
2026